C-RAD Gemini system is based on technology originally developed at CERN in Switzerland. Since then, the technology has been developed for use in medical applications by Professor Anders Brahme and his team at the Karolinska Institutet in Stockholm. C-RAD holds three patents, which ensures the protection of the unique technology. The C-RAD GEMini detector has a number of unique features. Opposite to present products on the market GEMini can be used both to make images with conventional x-ray and by using the beam of the radiation therapy machine. Gemini ED is mainly intended for use with the beam of the therapy unit. The image quality has been approved by a first potential customer and as a result negotiations have started. This company also has an interest to use the system for IGRT or so called Image Guided Radiation Therapy. Evaluations with other companies will be started. Two other companies have an interest to use the C-RAD GEMini system for fluence measurements when treating patients. A letter of intent, was for this application, signed with IBA Dosimetry. Based on a requirement specification, a technical and commercial evaluation is running. Erik Hedlund, CEO, C-RAD AB: "In 1998 the development of the GEMini technology started at the Karolinska Institutet in Stockholm. Since 2005 the group at C-RAD Imaging has been working hard to reach performances of the detector, required by clinics and companies working in radiation therapy. In 2010 C-RAD Imaging is expecting to make first deliveries of the GEMini detector. In addition diode detectors of 4.3 MSEK to IBA Dosimetry will be delivered." For further information: Erik Hedlund, CEO C-RAD AB, Telefon 018 - 66 69 31, E-post erik.hedlund@c-rad.se About C-RAD AB C-RAD develops new and innovative solutions for the use in advanced radiation therapy. The company group of C-RAD offers products and solutions for patient positioning, tumor localization and radiation treatment systems. End users are radiation therapy clinics worldwide. All product development is conducted in three fully owned subsidiaries; C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB. C-RAD Imaging AB is located in Östersund while the other companies are located in Uppsala. Numbers of employees are currently 19 people. The activity in C-RAD AB originates in research and development at the Karolinska Institutet in Solna and the The Royal Institute of Technology in Stockholm. Sales of the company's first product, the Sentinel system, started in autumn 2006. Co-operation agreements have been signed with the radiation therapy company Elekta and the Belgian company IBA. On major markets in Europe, North America and East Asia the company is represented by distributors normally specialized in radiation therapy. C-RAD is since July 2007 listed at Aktietorget. From 8 March 2010 C-RAD will be traded at OMX First North Premier.